Related Experiment Videos
Evaluation of seven- to nine-year-old children exposed to ritodrine in utero
Obstetrics and Gynecology
|October 1, 1984
Insights
Ritodrine exposure in preterm labor management did not significantly impact child growth, neurological development, or psychometric abilities by school age. Long-term follow-up showed no adverse effects in children exposed to this tocolytic agent.
Area of Science:
- Neonatal care
- Pediatric neurology
- Pharmacology
Background:
- Preterm labor management often involves tocolytic agents.
- Ritodrine was used to manage preterm labor.
- Concerns exist regarding potential long-term effects of in utero drug exposure.
Purpose of the Study:
- To evaluate the long-term neurodevelopmental and growth outcomes in children exposed to ritodrine during pregnancy.
- To compare children exposed to ritodrine with a matched control group.
Main Methods:
- Follow-up study of twenty children exposed to ritodrine between 24-34 weeks gestational age.
- Assessment at 7-9 years of age.
- Comparison with matched control subjects on growth, neurological, and psychometric parameters.
Main Results:
- No significant differences were observed in growth parameters between the ritodrine-exposed group and controls.
- Neurologic examinations revealed no significant variations.
- Psychometric testing showed comparable cognitive and developmental outcomes.
Conclusions:
- In utero exposure to ritodrine for preterm labor management does not appear to have significant adverse effects on growth, neurological development, or psychometric functioning in children by school age.
- These findings suggest a favorable long-term safety profile for ritodrine in this context.
Abstract:
Twenty children who had been exposed to ritodrine in the management of preterm labor between 24 and 34 weeks' gestational age were examined at seven to nine years of life and compared with matched control subjects. No significant differences were detected in factors of growth, neurologic findings, and psychometric testing.